These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 6144549

  • 1. Comparative pharmacokinetics of sulphasalazine and sulphapyridine after rectal and oral administration to patients with ulcerative colitis.
    Allgayer H, Kruis W, Eisenburg J, Paumgartner G.
    Eur J Clin Pharmacol; 1984; 26(2):275-7. PubMed ID: 6144549
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of serum concentrations of sulphasalazine and some of its metabolites after therapy by the oral or rectal route.
    Ashworth M, Arthur M, Turmer AD, Smith PR.
    Pharmatherapeutica; 1984; 3(8):551-5. PubMed ID: 6142465
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis.
    Cowan GO, Das KM, Eastwood MA.
    Br Med J; 1977 Oct 22; 2(6094):1057-9. PubMed ID: 21720
    [Abstract] [Full Text] [Related]

  • 8. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
    Klotz U.
    Clin Pharmacokinet; 1985 Oct 22; 10(4):285-302. PubMed ID: 2864155
    [Abstract] [Full Text] [Related]

  • 9. Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease.
    Das KM, Eastwood MA.
    Clin Pharmacol Ther; 1975 Nov 22; 18(5 Pt 1):514-20. PubMed ID: 241531
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative absorption of 5-aminosalicylic acid (5-ASA) after administration of a 5-ASA enema and salazosulfapyridine (SASP) after an SASP suppository in Japanese volunteers.
    Tokui K, Asai Y, Arakawa T, Matsumoto T, Nabeshima T.
    Biol Pharm Bull; 2002 Feb 22; 25(2):264-7. PubMed ID: 11853180
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Time course of free and N4-acetylated sulfapyridine concentrations in the plasma and saliva of man after sulfasalazine (salicylazosulfapyridine) administration: preliminary findings.
    Bates TR, Blumenthal HP, Pieniaszek HJ.
    Res Commun Chem Pathol Pharmacol; 1976 Sep 22; 15(1):183-9. PubMed ID: 9675
    [Abstract] [Full Text] [Related]

  • 18. [Drug therapy for ulcerative colitis: salazosulfapyridine and 5-ASA].
    Jo Y, Matsumoto T, Iida M.
    Nihon Rinsho; 2005 May 22; 63(5):820-4. PubMed ID: 15881176
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.
    Astbury C, Taggart AJ, Juby L, Zebouni L, Bird HA.
    Ann Rheum Dis; 1990 Aug 22; 49(8):587-90. PubMed ID: 1975737
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.